Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Qualigen Therapeutics, Inc. | President/CSO, Director | Stock Option (Right to Buy) | 130K | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QLGN | Qualigen Therapeutics, Inc. | Jul 11, 2022 | 1 | $0 | 4 | Aug 4, 2022 | President/CSO, Director |
QLGN | Qualigen Therapeutics, Inc. | Jun 14, 2022 | 1 | $18.6K | 4 | Jun 15, 2022 | President/CSO, Director |
QLGN | Qualigen Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | President/ChiefStrategyOfficer, Director |